Withholding temozolomide in glioblastoma patients with unmethylated MGMT promoter-still a dilemma?

Monika E. Hegi*, Roger Stupp

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

47 Scopus citations
Original languageEnglish (US)
Pages (from-to)1425-1427
Number of pages3
JournalNeuro-oncology
Volume17
Issue number11
DOIs
StatePublished - Nov 2015

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this